MAM
KYNB

Martingale Asset Management’s Kyntra Bio KYNB Stock Holding History

Martingale Asset Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-760
Closed -$51.3K – 806
2023
Q2 		$51.3K Sell
760
-330
-30% -$136K ﹤0.01% 793
2023
Q1 		$508K Sell
1,090
-433
-28% -$229K 0.01% 612
2022
Q4 		$610K Sell
1,523
-87
-5% -$33.3K 0.01% 583
2022
Q3 		$524K Sell
1,610
-51
-3% -$16.4K 0.01% 611
2022
Q2 		$439K Buy
1,661
+187
+13% +$47.8K 0.01% 667
2022
Q1 		$444K Sell
1,474
-320
-18% -$112K 0.01% 665
2021
Q4 		$633K Sell
1,794
-124
-6% -$38.6K 0.01% 592
2021
Q3 		$491K Buy
1,918
+1,013
+112% +$359K 0.01% 676
2021
Q2 		$603K Buy
905
+384
+74% +$221K 0.01% 541
2021
Q1 		$453K Hold
521
– – 0.01% 632
2020
Q4 		$483K Sell
521
-228
-30% -$240K 0.01% 625
2020
Q3 		$770K Sell
749
-36
-5% -$38.7K 0.01% 707
2020
Q2 		$796K Sell
785
-40
-5% -$37.1K 0.01% 785
2020
Q1 		$717K Buy
825
+48
+6% +$47.7K 0.01% 748
2019
Q4 		$833K Buy
777
+308
+66% +$314K 0.01% 797
2019
Q3 		$434K Buy
+469
New +$515K ﹤0.01% 897

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Martingale Asset Management's KYNB Position: Q3 2023 in Review

Martingale Asset Management sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 760 shares — an estimated $51.3K sold.

Martingale Asset Management first reported a position in KYNB in Q3 2019 and held it in 16 quarters. The position peaked at $833K in Q4 2019. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.

  • Martingale Asset Management reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
  • Martingale Asset Management sold 760 Kyntra Bio shares in Q3 2023, an estimated $51.3K.
  • Martingale Asset Management first reported a position in Kyntra Bio in Q3 2019 and held it in 16 quarters.
  • Martingale Asset Management's Kyntra Bio position peaked at $833K in Q4 2019.
  • 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.

Based on Martingale Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.